Ernexa Therapeutics Inc. (ERNA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 7.57M |
| Enterprise Value | 6.17M |
| P/E Ratio | -0.19 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.68 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.08 |
| Return On Equity | -2.64 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.84M |
| Net Income | -14.08M |
| Diluted EPS | -56 |
| Total Cash | 9.18M |
| Total Cash/Share | 11.59 |
| Total Debt | 389,000 |
| Total Debt/Equity | 0.06 |
| Current Ratio | 2.89 |
| Book Value Per Share | 8.66 |
| 52-Week Change | -90.18 |
| 52-Week High | 71.5 |
| 52-Week Low | 3.18 |
| Moving Average 50 Days | 7.37 |
| Moving Average 200 Days | 20.67 |
| Average Volume | 1.65M |
| Shares Outstanding | 314,124 |
| % Held by Institutions | 18.05 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | May 04, 2026 |